Godavari Biorefineries Ltd (GODAVARIB) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Godavari Biorefineries reported 12% YoY revenue growth in Q3 FY25, reaching Rs. 447 crores, driven by strong distillery performance and expanding bio-based chemical capacity.
- The company successfully deleveraged by repaying Rs. 240 crores of term debt using IPO proceeds, leading to reduced interest and principal payments from the current quarter onwards.
- Debottlenecking of the bio-based chemicals unit increased 1,3 butylene glycol production capacity from 120 to 200 tons per month.
- An exclusive India license agreement with Catalyxx Incorporated will enable the conversion of up to 30,000 metric tons of ethanol into biobutanol and higher alcohols annually.
- Despite headwinds like reduced sugar release quota and delayed sugarcane crushing, the company remains focused on operational excellence and sustainable growth.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.